MEDASCEND LIMITED

MEDASCEND LIMITED
Statement of Financial Position
As at 31 March 2025

	Notes	2025 £	2024 £
Fixed assets
Tangible fixed assets	3	1,790	4,601
		1,790	4,601
Current assets
Debtors	4	0	97
Cash at bank and in hand		4,386	8,154
		4,386	8,251
Creditors: amount falling due within one year	5	(3,204)	(10,592)
Net current assets		1,182	(2,341)

Total assets less current liabilities		2,972	2,260
Net assets		2,972	2,260

Capital and reserves
Called up share capital		15	15
Profit and loss account		2,957	2,245
Shareholders' funds		2,972	2,260

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 29 December 2025 and were signed by:

-------------------------------
U Nazir
Director

MEDASCEND LIMITED
Notes to the Financial Statements
For the year ended 31 March 2025

General Information

MEDASCEND LIMITED is a private company, limited by shares, registered in England and Wales, registration number 09492331, registration address 7 Standlake Avenue, Birmingham, B36 8JR.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)

Turnover

Turnover comprises the invoiced value of services supplied by the company, net of trade discounts.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Plant and Machinery	3 years Straight Line
Computer Equipment	3 years Straight Line

2.	Average number of employees Average number of employees during the year was 3 (2024 : 2).

Tangible fixed assets

Cost or valuation	Plant and Machinery	Computer Equipment	Total
	£	£	£
At 01 April 2024	7,353	5,796	13,149
Additions	168	2,191	2,359
Disposals	-	-	-
At 31 March 2025	7,521	7,987	15,508
Depreciation
At 01 April 2024	4,684	3,864	8,548
Charge for year	2,507	2,663	5,170
On disposals	-	-	-
At 31 March 2025	7,191	6,527	13,718
Net book values
Closing balance as at 31 March 2025	330	1,460	1,790
Opening balance as at 01 April 2024	2,669	1,932	4,601

Debtors: amounts falling due within one year

	2025 £		2024 £
PAYE & Social Security	0		97
	0		97

Creditors: amount falling due within one year

	2025 £	2024 £
Corporation Tax	1,835	9,912
Accrued Expenses	1,347	663
Other Creditors	(1)	(1)
Directors' Current Accounts	23	18
	3,204	10,592

Registered Number: 09492331
England and Wales
MEDASCEND LIMITED

Unaudited Financial Statements

Period of accounts Start date: 01 April 2024 End date: 31 March 2025